SARS-CoV-2 Vaccine Improved Hemostasis of a Patient with Protein S Deficiency: A Case Report.

Humans Female COVID-19 / blood SARS-CoV-2 / immunology Protein S Deficiency / genetics Adolescent COVID-19 Vaccines / immunology Hemostasis Protein S / metabolism Mutation, Missense
COVID-19 COVID-19 vaccination Pfizer vaccine protein S protein S deficiency thrombosis

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Oct 2024
Historique:
received: 14 09 2024
revised: 01 10 2024
accepted: 03 10 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

A 16-year-old patient, while an infant, incurred right-sided hemiparesis and had difficulty breast feeding. She was later diagnosed with a neonatal stroke and her genetic testing showed a missense mutation in her

Identifiants

DOI: 10.3390/ijms251910717 PMID: 39409046
pubmed: 39409046
pii: ijms251910717
doi: 10.3390/ijms251910717
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
Protein S 0
PROS1 protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Mohammad A Mohammad (MA)

Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.
ORCID: 0009-0005-4199-8385

Alaa Malik (A)

Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.
ORCID: 0009-0004-0875-8438

Lekha Thangada (L)

Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.

Diana Polanía-Villanueva (D)

Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
ORCID: 0000-0002-7846-2948

Jovanny Zabaleta (J)

Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.
Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
ORCID: 0000-0002-5961-6761

Rinku Majumder (R)

Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.
ORCID: 0000-0002-1727-7220

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Hémopathies et maladies lymphatiques › Hémopathies › Thrombophilie › Déficit en protéine S › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Personnes › Tranches d'âge › Adolescent › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre la COVID-19 › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hémostase › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Facteurs biologiques › Inhibiteurs des facteurs de la coagulation sanguine › Protéine S › SARS-CoV-2 Vaccine Improved Hemostasis of a...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Mutation faux-sens › SARS-CoV-2 Vaccine Improved Hemostasis of a...